Human Molecular Genetics, 2002, Vol. 11, No. 13 1569-1579
© 2002 Oxford University Press
Loss of phosphatase activity in myotubularin-related protein 2 is associated with CharcotMarieTooth disease type 4B1
1Institute of Cell Biology, Department of Biology, Swiss Federal Institute of Technology, ETH-Hönggerberg, CH-8093 Zürich, Switzerland and 2Institute of Biochemistry, University of Fribourg, CH-1700 Fribourg, Switzerland
Received March 13, 2002; Accepted April 22, 2002
Mutations in the gene encoding myotubularin-related protein 2 (MTMR2) are responsible for autosomal recessive CharcotMarieTooth disease type 4B1 (CMT4B1), a severe hereditary motor and sensory neuropathy characterized by focally folded myelin sheaths and demyelination. MTMR2 belongs to the myotubularin family, which is characterized by the presence of a phosphatase domain. Myotubularin (MTM), the archetype member of this family, is mutated in X-linked myotubular myopathy. Although MTMR2 and MTM are closely related, they are likely to have different functions. Recent studies revealed that MTM dephosphorylates specifically phosphatidylinositol 3-phosphate. Here we analyze the biochemical properties of the mouse Mtmr2 protein, which shares 97% amino acid identity with human MTMR2. We show that phosphatidylinositol-3-phosphate is also a substrate for Mtmr2, but, unlike myotubularin, Mtmr2 dephosphorylates phosphatidylinositol 3,5-bisphosphate with high efficiency and peak activity at neutral pH. We demonstrate that the known disease-associated MTMR2 mutations lead to dramatically reduced phosphatase activity, suggesting that the MTMR2 phosphatase activity is crucial for the proper function of peripheral nerves in CMT4B1. Expression analysis of Mtmr2 suggests particularly high levels in neurons. Thus, the demyelinating neuropathy CMT4B1 might be triggered by the malfunction of neural membrane recycling, membrane trafficking, and/or endocytic or exocytotic processes, combined with altered axonSchwann cell interactions. Furthermore, the different biochemical properties of MTM and MTMR2 offer a potential explanation for the different human diseases caused by mutations in their respective genes.
* To whom correspondence should be addressed. Tel: +41 1 6333432; Fax: +41 1 6331190; Email: usuter{at}cell.biol.ethz.ch
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Cao, J. M. Backer, J. Laporte, E. J. Bedrick, and A. Wandinger-Ness Sequential Actions of Myotubularin Lipid Phosphatases Regulate Endosomal PI(3)P and Growth Factor Receptor Trafficking Mol. Biol. Cell, August 1, 2008; 19(8): 3334 - 3346. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tersar, M. Boentert, P. Berger, S. Bonneick, C. Wessig, K. V. Toyka, P. Young, and U. Suter Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2 Hum. Mol. Genet., December 15, 2007; 16(24): 2991 - 3001. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Gaboreanu, R. Hrstka, W. Xu, M. Shy, J. Kamholz, J. Lilien, and J. Balsamo Myelin protein zero/P0 phosphorylation and function require an adaptor protein linking it to RACK1 and PKC{alpha} J. Cell Biol., May 21, 2007; 177(4): 707 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Tosch, H. M. Rohde, H. Tronchere, E. Zanoteli, N. Monroy, C. Kretz, N. Dondaine, B. Payrastre, J.-L. Mandel, and J. Laporte A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy Hum. Mol. Genet., November 1, 2006; 15(21): 3098 - 3106. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lorenzo, S. Urbe, and M. J. Clague Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosomerelated functions J. Cell Sci., July 15, 2006; 119(14): 2953 - 2959. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Berger, I. Berger, C. Schaffitzel, K. Tersar, B. Volkmer, and U. Suter Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2 Hum. Mol. Genet., February 15, 2006; 15(4): 569 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Begley, G. S. Taylor, M. A. Brock, P. Ghosh, V. L. Woods, and J. E. Dixon Molecular basis for substrate recognition by MTMR2, a myotubularin family phosphoinositide phosphatase PNAS, January 24, 2006; 103(4): 927 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bonneick, M. Boentert, P. Berger, S. Atanasoski, N. Mantei, C. Wessig, K. V. Toyka, P. Young, and U. Suter An animal model for Charcot-Marie-Tooth disease type 4B1 Hum. Mol. Genet., December 1, 2005; 14(23): 3685 - 3695. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Robinson and J. E. Dixon The Phosphoinositide-3-phosphatase MTMR2 Associates with MTMR13, a Membrane-associated Pseudophosphatase Also Mutated in Type 4B Charcot-Marie-Tooth Disease J. Biol. Chem., September 9, 2005; 280(36): 31699 - 31707. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, C.-h. Wong, W. Xia, D. D. Mruk, N. P. Y. Lee, W. M. Lee, and C. Y. Cheng Regulation of Sertoli-Germ Cell Adherens Junction Dynamics via Changes in Protein-Protein Interactions of the N-Cadherin-{beta}-Catenin Protein Complex which Are Possibly Mediated by c-Src and Myotubularin-Related Protein 2: An in Vivo Study Using an Androgen Suppression Model Endocrinology, March 1, 2005; 146(3): 1268 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bolino, A. Bolis, S. C. Previtali, G. Dina, S. Bussini, G. Dati, S. Amadio, U. Del Carro, D. D. Mruk, M. L. Feltri, et al. Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis J. Cell Biol., November 22, 2004; 167(4): 711 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Roth Phosphoinositides in Constitutive Membrane Traffic Physiol Rev, July 1, 2004; 84(3): 699 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tronchere, J. Laporte, C. Pendaries, C. Chaussade, L. Liaubet, L. Pirola, J.-L. Mandel, and B. Payrastre Production of Phosphatidylinositol 5-Phosphate by the Phosphoinositide 3-Phosphatase Myotubularin in Mammalian Cells J. Biol. Chem., February 20, 2004; 279(8): 7304 - 7312. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dang, Z. Li, E. Y. Skolnik, and H. Fares Disease-related Myotubularins Function in Endocytic Traffic in Caenorhabditis elegans Mol. Biol. Cell, January 1, 2004; 15(1): 189 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chaussade, L. Pirola, S. Bonnafous, F. Blondeau, S. Brenz-Verca, H. Tronchere, F. Portis, S. Rusconi, B. Payrastre, J. Laporte, et al. Expression of Myotubularin by an Adenoviral Vector Demonstrates Its Function as a Phosphatidylinositol 3-Phosphate [PtdIns(3)P] Phosphatase in Muscle Cell Lines: Involvement of PtdIns(3)P in Insulin-Stimulated Glucose Transport Mol. Endocrinol., December 1, 2003; 17(12): 2448 - 2460. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Laporte, F. Bedez, A. Bolino, and J.-L. Mandel Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases Hum. Mol. Genet., October 15, 2003; 12(90002): R285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Berger, C. Schaffitzel, I. Berger, N. Ban, and U. Suter Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module PNAS, October 14, 2003; 100(21): 12177 - 12182. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Nandurkar, M. Layton, J. Laporte, C. Selan, L. Corcoran, K. K. Caldwell, Y. Mochizuki, P. W. Majerus, and C. A. Mitchell Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP PNAS, July 22, 2003; 100(15): 8660 - 8665. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Previtali, B. Zerega, D. L. Sherman, P. J. Brophy, G. Dina, R. H.M. King, M. M. Salih, L. Feltri, A. Quattrini, R. Ravazzolo, et al. Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve Hum. Mol. Genet., July 15, 2003; 12(14): 1713 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-A Kim, P. O. Vacratsis, R. Firestein, M. L. Cleary, and J. E. Dixon Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase PNAS, April 15, 2003; 100(8): 4492 - 4497. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Senderek, C. Bergmann, S. Weber, U.-P. Ketelsen, H. Schorle, S. Rudnik-Schoneborn, R. Buttner, E. Buchheim, and K. Zerres Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15 Hum. Mol. Genet., February 1, 2003; 12(3): 349 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Di Giaimo, M. Riccio, S. Santi, C. Galeotti, D. C. Ambrosetti, and M. Melli New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B Hum. Mol. Genet., November 1, 2002; 11(23): 2941 - 2950. [Abstract] [Full Text] [PDF] |
||||








